Qdenga could be responsible for enhancing dengue in children who have not had an infection yet in their lives. In such cases, the vaccine could simulate a primary dengue infection in the body, resulting in protection against DENV-1 and DENV-2 infections but not against a DENV-3 infection.

Ensuring adequate uptake of the Qdenga dengue vaccine among vulnerable populations in India will require the government to secure a lower price

Qdenga could be responsible for enhancing dengue in children who have not had an infection yet in their lives. In such cases, the vaccine could simulate a primary dengue infection…